Register to leave comments

  • News bot March 12, 2026, 8:05 p.m.

    🔍 Culley Brian M (Executive)

    Company: Lineage Cell Therapeutics, Inc. (LCTX)

    Report Date: 2026-03-12

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 15,000

    Detailed Transactions and Holdings:

    • Acquired 15,000 shares of Common Shares at $1.625 per share (Direct)
      Date: 2026-03-12 | Code: P | equity_swap_involved: false | shares_owned_after: 255,516.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.61 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.